Navigation Links
Cancer protein's surprising role as memory regulator
Date:9/22/2011

BOSTON--Scientists at Dana-Farber Cancer Institute and Harvard Medical School have found that a common cancer protein leads a second, totally different life in normal adult brain cells: It helps regulates memory formation and may be implicated in Alzheimer's disease.

Cyclin E is a well-known culprit that drives many types of solid tumors and blood cancers. The report, published online in Developmental Cell, is the first revelation that cyclin E has a crucial role in the formation of nerve connections, or synapses, in the brain. Synapses are tiny connections between brain cells where memories are stored.

"This protein has a double life," said Peter Sicinski, PhD, a cancer biologist at Dana-Farber and senior author of the publication. "It is overexpressed in many different cancers, but it also is expressed in high levels in the human brain. We have found that cyclin E is needed for memory formation and is a very important player."

The researchers found potential evidence linking cyclin E to Alzheimer's disease, because it binds to an enzyme called Cdk5 that is involved in memory.

"There is good evidence that hyperactivity of Cdk5 contributes to Alzheimer's disease and inhibiting this enzyme can ameliorate symptoms in animals," said Sicinski, who is also a professor of Genetics at Harvard Medical School. "Manipulating cyclin E levels might be another way to accomplish this."

The scientists didn't test cyclin E in Alzheimer's mice, but they did show that when cyclin E binds to Cdk5 molecules, it locks them away in an unusable form. Moreover, when the researchers reduced cyclin E levels in mouse brain cells, fewer nerve connections formed and the animals' memories suffered.

Cyclins are a family of related proteins found in dividing cells. They serve as biological switches, controlling a cell's progression from one phase of its life cycle to the next. The actual signals to exit one phase and enter the next are issued by enzymes called cyclin-dependent kinases, or Cdks, that bind to cyclins.

Many types of cancer cells, including breast, ovarian, colon, and blood cancers, are driven by the overexpression of cyclin E, which acts like a car's accelerator pressed to the floor, speeding the cells through their growth-and-division cycle and allowing tumors to form and spread.

Though cyclin E is mainly found in dividing cells, researchers discover about a decade ago that cyclin E is also plentiful in adult, differentiated brain cells. But what it was doing there, no one knew.

In the current Developmental Cell paper, Junko Odajima, PhD, a postdoctoral fellow in the Sicinski laboratory and the paper's co-lead author (with Zachary P. Wills, PhD, from Harvard Medical School), showed that cyclin E in the brain attaches itself to the Cdk5 enzyme. When cyclin E molecules bind to and inactive Cdk5, synapses formation is increased, and, presumably, memory function improves.

Odajima tested this idea using a standard memory and learning test in which mice swimming in water must find a submerged platform to rest on, and remember its location in subsequent trials. The researchers then move the platform, requiring the animals to "forget" its previous location and learn and remember the new one.

As their hypothesis had suggested, mice deficient in cyclin E performed worse than rodents who had a normal amount of cyclin E. This contrast highlighted the importance of cyclin E for learning and memory.

Whether cyclin E levels rise and fall in the mouse brain during learning tasks is a topic of further research, said the scientists, who also plan to determine whether abnormal cyclin E levels can be linked to neurological diseases and learning disorders.


'/>"/>

Contact: Bill Schaller
william_schaller@dfci.harvard.edu
617-632-5357
Dana-Farber Cancer Institute
Source:Eurekalert  

Related biology news :

1. UCLA researchers develop system that finds prostate cancer spread earlier than conventional imaging
2. Another step toward resisting breast cancer
3. SuviCa Inc. of Boulder to commercialize CU-Boulder cancer screening technology
4. Soy peptide + chemo drug block colon cancers spread to liver
5. Oncologists recognized by ESMO for outstanding contributions to cancer research and treatment
6. Purdue technology used in first fluorescence-guided ovarian cancer surgery
7. AACR to host conference on the science of cancer health disparities
8. MU researchers unveil new method for detecting lung cancer in Nature article
9. Protein found in heart may be target for colon cancer therapies
10. Plant compound reduces breast cancer mortality
11. Primary component in turmeric kicks off cancer-killing mechanisms in human saliva
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cancer protein's surprising role as memory regulator
(Date:1/6/2017)...  SomaLogic announced today that it has agreed ... iCarbonX, the China -based company ... Health Ecosystem that can define each person,s ,digital ... behavioral and psychological data, the Internet and artificial ... will provide proteomics data and applications expertise to ...
(Date:1/3/2017)... , Jan. 3, 2017 Onitor, provider ... introduction of Onitor Track, an innovative biometric data-driven program ... showcasing this month at the 2017 Consumer Electronics Show ... In the U.S., the World Health Organization ... than two-thirds of adults who are overweight or obese. ...
(Date:12/20/2016)... 2016   Valencell , the leading innovator ... STMicroelectronics (NYSE: STM), a global semiconductor leader serving ... today the launch of a new, highly accurate ... includes ST,s compact SensorTile turnkey multi-sensor ... sensor system. Together, SensorTile and Benchmark deliver the ...
Breaking Biology News(10 mins):
(Date:1/12/2017)... MD (PRWEB) , ... January ... ... the market’s rapid adoption of Limfinity® Cloud, RURO has enhanced the platform ... cross-continent user groups, federated login, rapid data searching, and more. In addition ...
(Date:1/11/2017)... -- Brian Mehling, M.D., world-renowned stem cell researcher, board-certified orthopedic ... will be attending the 47th Annual World Economic Forum ... 17-20, 2017. This will be Dr. Mehling,s fifth year ... this year,s forum is Responsive and Responsible Leadership; over ... for fostering greater social inclusion and human development. One-third ...
(Date:1/11/2017)... ... 11, 2017 , ... For many fledging startups, good advice ... young businesses face. With the second installment of Quorum’s newest signature program, Entrepreneur ... Founder and Principal of interactive design agency, P’unk Ave. , For the ...
(Date:1/11/2017)... , Jan. 11, 2017 AnaptysBio, Inc., ... candidates focused on unmet medical needs in inflammation, ... as chief financial officer.  Mr. Piscitelli will ... as well as overseeing the company,s accounting and ... pleased to welcome Dominic to the senior management ...
Breaking Biology Technology: